MAP3K8 Antikörper (pThr290)
(1 reference)-
- Target Alle MAP3K8 Antikörper anzeigen
- MAP3K8 (Mitogen-Activated Protein Kinase Kinase Kinase 8 (MAP3K8))
-
Bindungsspezifität
- pThr290
-
Reaktivität
- Human
-
Wirt
- Kaninchen
-
Klonalität
- Polyklonal
-
Konjugat
- Dieser MAP3K8 Antikörper ist unkonjugiert
-
Applikation
- ELISA, Dot Blot (DB)
- Verwendungszweck
- Rabbit polyclonal antibody raised against synthetic phosphopeptide of MAP3K8.
- Kreuzreaktivität
- Human
- Immunogen
- Synthetic phosphopeptide (conjugated with KLH) corresponding to residues surrounding T290 of human MAP3K8.
- Top Product
- Discover our top product MAP3K8 Primärantikörper
-
anti-Mitogen-Activated Protein Kinase Kinase Kinase 8 (MAP3K8) (AA 121-220) antibody
MAP3K8 Reaktivität: Human, Ratte, Maus WB, ELISA, IHC (p) Wirt: Kaninchen Polyclonal unconjugated
anti-Mitogen-Activated Protein Kinase Kinase Kinase 8 (MAP3K8) (AA 1-300) antibodyMAP3K8 Reaktivität: Human ELISA, IHC, IF Wirt: Kaninchen Polyclonal unconjugated
anti-Mitogen-Activated Protein Kinase Kinase Kinase 8 (MAP3K8) antibodyMAP3K8 Reaktivität: Human WB, IHC (p), IF, ICC Wirt: Kaninchen Polyclonal unconjugated
anti-Mitogen-Activated Protein Kinase Kinase Kinase 8 (MAP3K8) (pThr290) antibodyMAP3K8 Reaktivität: Human, Ratte, Maus WB, ELISA, IHC, IF, ICC Wirt: Kaninchen Polyclonal unconjugated
anti-Mitogen-Activated Protein Kinase Kinase Kinase 8 (MAP3K8) (AA 368-397), (C-Term) antibodyMAP3K8 Reaktivität: Human WB, IHC (p) Wirt: Kaninchen Polyclonal RB03467 unconjugated
anti-Mitogen-Activated Protein Kinase Kinase Kinase 8 (MAP3K8) (AA 256-305) antibodyMAP3K8 Reaktivität: Human, Ratte, Maus WB, ELISA, IHC, IHC (p), IF Wirt: Kaninchen Polyclonal unconjugated
anti-Mitogen-Activated Protein Kinase Kinase Kinase 8 (MAP3K8) (Ser400) antibodyMAP3K8 Reaktivität: Human WB, ELISA, IHC Wirt: Kaninchen Polyclonal unconjugated
anti-Mitogen-Activated Protein Kinase Kinase Kinase 8 (MAP3K8) (pSer290) antibodyMAP3K8 Reaktivität: Human, Ratte, Maus, Rind (Kuh), Affe WB, IHC, IF, IC Wirt: Kaninchen Polyclonal unconjugated
anti-Mitogen-Activated Protein Kinase Kinase Kinase 8 (MAP3K8) (pThr290) antibodyMAP3K8 Reaktivität: Human WB, ELISA, IHC, IF Wirt: Kaninchen Polyclonal unconjugated
anti-Mitogen-Activated Protein Kinase Kinase Kinase 8 (MAP3K8) (pSer400) antibodyMAP3K8 Reaktivität: Human, Ratte, Maus WB, ELISA, IHC (p), IF (cc), IF (p), IHC (fro), FACS Wirt: Kaninchen Polyclonal unconjugated
-
- Applikationshinweise
-
ELISA (1:1000)
Dot Blot (1:500)
The optimal working dilution should be determined by the end user. - Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Liquid
- Buffer
- In PBS (0.09 % sodium azide)
- Konservierungsmittel
- Sodium azide
- Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Lagerung
- 4 °C,-20 °C
- Informationen zur Lagerung
-
Store at 4°C. For long term storage store at -20°C.
Aliquot to avoid repeated freezing and thawing.
-
-
: "COT kinase proto-oncogene expression in T cells: implication of the JNK/SAPK signal transduction pathway in COT promoter activation." in: The Journal of biological chemistry, Vol. 275, Issue 40, pp. 31379-86, (2000) (PubMed).
-
: "COT kinase proto-oncogene expression in T cells: implication of the JNK/SAPK signal transduction pathway in COT promoter activation." in: The Journal of biological chemistry, Vol. 275, Issue 40, pp. 31379-86, (2000) (PubMed).
-
- Target
- MAP3K8 (Mitogen-Activated Protein Kinase Kinase Kinase 8 (MAP3K8))
- Andere Bezeichnung
- MAP3K8 / TPL-2 (MAP3K8 Produkte)
- Synonyme
- MAP3K8 antikoerper, COT antikoerper, EST antikoerper, ESTF antikoerper, MEKK8 antikoerper, TPL2 antikoerper, Tpl-2 antikoerper, c-COT antikoerper, Cot antikoerper, Cot/Tpl2 antikoerper, Est antikoerper, Estf antikoerper, Tpl2 antikoerper, D17TPL2 antikoerper, mitogen-activated protein kinase kinase kinase 8 antikoerper, MAP3K8 antikoerper, map3k8 antikoerper, Map3k8 antikoerper
- Gen-ID
- 1326
- Pathways
- PI3K-Akt Signalweg, T-Zell Rezeptor Signalweg
-
